Skip to Content

Current Oncology, Volume 31, Issue 11

2024 November - 68 articles

Cover Story: Antibody drug conjugates (ADCs) are a new class of therapeutic agents designed to target specific antigens on tumor cells, combining the specificity of monoclonal antibodies with the cytotoxicity of chemotherapy agents. Currently, overall, more than 150 ADCs are in clinical trials. ADCs have been available for over a decade, but in gynecological cancers, ADCs have recently come up as a second-line treatment option. Moreover, newer techniques have been incorporated and next-generation ADCs have been created. Some examples include bispecific antibodies, probody drug conjugates (PDCs), immune-stimulating ADCs, degrader–antibody conjugates (DACs), and ADCs with dual chemotherapy. With so much in the pipeline, particularly with the newer techniques, this holds great promise for future. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (68)

  • Article
  • Open Access
1 Citations
3,042 Views
14 Pages

Programmed Cell Death-Ligand 1 Expression and Clinical Outcomes Among Patients with Resected, Early-Stage Non-Small Cell Lung Cancer: A Real-World Study

  • Parneet K. Cheema,
  • Iqra Syed,
  • Femida Gwadry-Sridhar,
  • Muhammad Rakibuz-Zaman and ,
  • Robin Sachdeva,
  • Alec Pencz,
  • Luna Zhan,
  • Katrina Hueniken,
  • Devalben Patel and
  • M. Sara Kuruvilla
  • + 13 authors+ 8 authors

31 October 2024

Treatment options for non-small cell lung cancer (NSCLC) are evolving, given recent and expected approvals of immune checkpoint inhibitors (ICIs) targeting programmed cell death-(ligand) 1 (PD-1/PD-L1). We retrospectively evaluated outcomes among pat...

  • Brief Report
  • Open Access
1 Citations
2,513 Views
12 Pages

29 October 2024

Helicobacter pylori, a gram-negative, flagellated, helical bacterium, is a common cause of chronic gastric infection worldwide. According to the World Health Organization, H. pylori infection, a specific carcinogenic factor, was the leading cause of...

(This article belongs to the Section Gastrointestinal Oncology)
  • Article
  • Open Access
1 Citations
2,961 Views
12 Pages

Clinical Outcomes of Poly(ADP–Ribose) Polymerase Inhibitors as Maintenance Therapy in Patients with Ovarian Cancer in the Southeastern Region of Korea

  • Hyeong In Ha,
  • Hyung Joon Yoon,
  • Changho Song,
  • Eun Taeg Kim and ,
  • Dong-Soo Suh,
  • Ki Hyung Kim,
  • Yong Jin Na and
  • Yong Jung Song
  • + 3 authors+ 0 author

28 October 2024

Purpose: In this study, we aimed to retrospectively investigate the real-world clinical efficacy and adverse events of poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP) inhibitors in real-world clinical practice among patients with newly dia...

(This article belongs to the Section Gynecologic Oncology)
  • Article
  • Open Access
8 Citations
3,643 Views
12 Pages

Quality of Life and Symptoms of Hospitalized Hematological Cancer Patients

  • Theocharis I. Konstantinidis,
  • Ioanna Tsatsou,
  • Eleftheria Tsagkaraki,
  • Evgenia Chasouraki and ,
  • Maria Saridi,
  • Theodoula Adamakidou and
  • Ourania Govina
  • + 2 authors+ 0 author

28 October 2024

Patients with hematological malignancies undergo intensive treatment and prolonged hospitalization, thus having a variety of physical and psychosocial symptoms and worse quality of life (QOL). This study aimed to assess the QOL and investigate the sy...

(This article belongs to the Section Psychosocial Oncology)
  • Review
  • Open Access
2 Citations
3,334 Views
13 Pages

The Management of Non-Muscle-Invasive Bladder Cancer in a Veteran Patient Population: Issues and Recommendations

  • Jennifer Taylor,
  • Sagar Patel,
  • Krishnanath Gaitonde,
  • Kirsten Greene and ,
  • Joseph C. Liao,
  • Glen McWilliams,
  • Mark Sawyer,
  • Florian Schroeck,
  • Aly Alrabaa and
  • Jeffrey Jones
  • + 7 authors+ 2 authors

28 October 2024

The ability of the Veterans Health Administration System to care for veterans with bladder cancer is influenced by the increased complexity of both veterans and the system’s capacity to do so, which is determined by personnel and equipment allo...

  • Article
  • Open Access
9 Citations
3,422 Views
13 Pages

Prognostic Value of Sarcopenia in Elderly Patients with Metastatic Non-Small-Cell Lung Cancer Undergoing Radiotherapy

  • Valerio Nardone,
  • Alfonso Reginelli,
  • Vittorio Patanè,
  • Angelo Sangiovanni and ,
  • Roberta Grassi,
  • Anna Russo,
  • Pierpaolo Correale,
  • Diego Sandro Giordano,
  • Carmine Zaccaria and
  • Salvatore Cappabianca
  • + 6 authors+ 1 author

25 October 2024

Background: Sarcopenia, a syndrome characterized by age-related loss of muscle mass and function, lacks universally accepted diagnostic criteria, particularly for its role as a prognostic factor in elderly patients with non-small-cell lung cancer (NS...

(This article belongs to the Section Thoracic Oncology)
  • Communication
  • Open Access
3,101 Views
14 Pages

Surgical Considerations in Treating Central Nervous System Lymphomas: A Case Series of 11 Patients

  • Corneliu Toader,
  • Adrian Vasile Dumitru,
  • Mugurel Petrinel Radoi,
  • Luca-Andrei Glavan and ,
  • Milena-Monica Ilie,
  • Razvan-Adrian Covache-Busuioc,
  • Vlad Buica,
  • Antonio-Daniel Corlatescu,
  • Horia-Petre Costin and
  • Alexandru Vlad Ciurea
  • + 6 authors+ 1 author

25 October 2024

In this retrospective unicentric study, we analyzed the medical records of 11 patients who were surgically treated for CNS lymphoma, both primary and secondary, between 2009 and 2024. Given the rarity of CNS lymphomas and their diverse signs and symp...

  • Review
  • Open Access
14 Citations
6,951 Views
27 Pages

Acute Myeloid Leukemia in Older Patients: From New Biological Insights to Targeted Therapies

  • Pasquale Niscola,
  • Valentina Gianfelici,
  • Gianfranco Catalano,
  • Marco Giovannini and ,
  • Carla Mazzone,
  • Nelida Ines Noguera and
  • Paolo de Fabritiis
  • + 2 authors+ 0 author

24 October 2024

Acute myeloid leukemia (AML) is a heterogeneous blood-related neoplasm that predominantly afflicts older adults with a poor prognosis due to their physical condition and the presence of medical accompanying comorbidities, adverse biological disease f...

(This article belongs to the Section Hematology)
  • Case Report
  • Open Access
3 Citations
2,744 Views
11 Pages

A Novel Oncogenic and Drug-Sensitive KIF5B-NTRK1 Fusion in Lung Adenocarcinoma

  • Hui Li,
  • Huicong Liu,
  • Lisha Xiao,
  • Huabin Gao and ,
  • Huiting Wei,
  • Anjia Han and
  • Gengpeng Lin
  • + 2 authors+ 0 author

24 October 2024

We present a case of a lung adenocarcinoma patient harboring a novel kinesin family member 5B (KIF5B)-NTRK1 gene fusion that responds well to entrectinib. Moreover, KIF5B-NTRK1 gene chimera has been shown to be an oncogene, activating both the MAPK a...

(This article belongs to the Section Thoracic Oncology)
  • Article
  • Open Access
9 Citations
4,613 Views
13 Pages

24 October 2024

Despite the generally good prognosis of differentiated thyroid cancer (DTC), impairments in health-related quality of life (HRQoL) remain a major concern in these patients. This study examined the patterns and predictors of change in mental and physi...

(This article belongs to the Section Psychosocial Oncology)
  • Article
  • Open Access
4 Citations
2,479 Views
10 Pages

The Efficacy of MRI-Based ADC Measurements in Detecting Axillary Lymph Node Metastasis: Evaluation of a Prospective Study

  • Faruk Türkeş,
  • Özcan Dere,
  • Funda Dinç,
  • Cenk Yazkan and ,
  • Önder Özcan and
  • Okay Nazlı
  • + 1 author+ 0 author

24 October 2024

Objective: This study aimed to evaluate the efficacy of MRI-based Apparent Diffusion Coefficient (ADC) measurements in detecting axillary lymph node metastasis in breast cancer patients. By comparing preoperative MRI findings with intraoperative sent...

  • Article
  • Open Access
21 Citations
4,934 Views
21 Pages

Predicting Breast Cancer Relapse from Histopathological Images with Ensemble Machine Learning Models

  • Ghanashyam Sahoo,
  • Ajit Kumar Nayak,
  • Pradyumna Kumar Tripathy,
  • Amrutanshu Panigrahi and ,
  • Abhilash Pati,
  • Bibhuprasad Sahu,
  • Chandrakanta Mahanty and
  • Saurav Mallik
  • + 3 authors+ 0 author

24 October 2024

Relapse and metastasis occur in 30–40% of breast cancer patients, even after targeted treatments like trastuzumab for HER2-positive breast cancer. Accurate individual prognosis is essential for determining appropriate adjuvant treatment and ear...

  • Review
  • Open Access
3 Citations
4,379 Views
9 Pages

24 October 2024

Despite significant advancements in neuro-oncology, management of glioblastoma remains a formidable challenge. Over the last century, the role and goals of surgery for patients with glioblastoma have evolved dramatically, with surgical intervention m...

(This article belongs to the Special Issue Treatment for Glioma: Retrospect and Prospect)
  • Guidelines
  • Open Access
9 Citations
12,403 Views
32 Pages

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Setting

  • Mita Manna,
  • Karen A. Gelmon,
  • Jean-François Boileau,
  • Christine Brezden-Masley and ,
  • Jeffrey Q. Cao,
  • Katarzyna J. Jerzak,
  • Ipshita Prakash,
  • Sandeep Sehdev,
  • Christine Simmons and
  • Jan-Willem Henning
  • + 15 authors+ 10 authors

24 October 2024

Human epidermal growth factor receptor 2-positive (HER2+) breast cancer is an aggressive subtype of breast cancer associated with a poor prognosis when sub-optimally treated. Recent advances include new and effective targeted therapies that have sign...

(This article belongs to the Special Issue From Screening to Treatment: Technology’s Impact on Breast Cancer Care)
  • Guidelines
  • Open Access
5 Citations
4,566 Views
24 Pages

Esophagitis and Pneumonitis Related to Concurrent Chemoradiation ± Durvalumab Consolidation in Unresectable Stage III Non-Small-Cell Lung Cancer: Risk Assessment and Management Recommendations Based on a Modified Delphi Process

  • Anthony M. Brade,
  • Houda Bahig,
  • Andrea Bezjak,
  • Rosalyn A. Juergens and ,
  • Charmaine Lynden,
  • Nicolas Marcoux,
  • Barbara Melosky,
  • Devin Schellenberg and
  • Stephanie Snow
  • + 4 authors+ 0 author

23 October 2024

The addition of durvalumab consolidation to concurrent chemoradiation therapy (cCRT) has fundamentally changed the standard of care for patients with unresectable stage III non-small-cell lung cancer (NSCLC). Nevertheless, concerns related to esophag...

  • Article
  • Open Access
5 Citations
3,626 Views
10 Pages

Prognostic Factors for Patients with Small-Cell Lung Cancer Treated with Chemoimmunotherapy: A Retrospective Multicenter Study

  • Takashi Hatori,
  • Takeshi Numata,
  • Toshihiro Shiozawa,
  • Manato Taguchi and ,
  • Hirofumi Sakurai,
  • Tomohiro Tamura,
  • Jun Kanazawa,
  • Hiroaki Tachi,
  • Kyoko Kondo and
  • Nobuyuki Hizawa
  • + 9 authors+ 4 authors

23 October 2024

Background: This study aimed to investigate prognostic factors for predicting the survival of patients with extensive-disease-stage small-cell lung cancer treated with chemoimmunotherapy. Methods: Patients were classified according to overall surviva...

(This article belongs to the Special Issue Immunotherapy in Thoracic Malignancies)
  • Article
  • Open Access
11 Citations
7,643 Views
14 Pages

Two-Step Screening for Depression and Anxiety in Patients with Cancer: A Retrospective Validation Study Using Real-World Data

  • Bryan Gascon,
  • Joel Elman,
  • Alyssa Macedo,
  • Yvonne Leung and ,
  • Gary Rodin and
  • Madeline Li
  • + 1 author+ 0 author

23 October 2024

Background: Although screening for distress is recommended by many cancer care guidelines, the uptake of such screening in cancer centers remains limited. Improving the acceptability of screening programs in cancer centers requires a reduction in cli...

(This article belongs to the Special Issue Building Hope for the Next Decade of Psychosocial Oncology: Optimizing the Integration of Supportive Care into Oncology Care)
  • Article
  • Open Access
4,490 Views
13 Pages

Clinical Outcome Patterns of Use of Radium-223 in Patients with Metastatic Castration-Resistant Prostate Cancer

  • Colleen Mackenzie,
  • Jasna Deluce,
  • Morgan Black,
  • Emma Churchman and ,
  • Eric Winquist,
  • Scott Ernst,
  • David T. Laidley,
  • Matthew Parezanovic,
  • Kylea Potvin and
  • Ricardo Fernandes
  • + 5 authors+ 0 author

22 October 2024

Introduction: Radium-223 dichloride (radium-223) is a bone-targeting radioisotope therapy that aids in the survival of patients with metastatic castration-resistant prostate cancer (mCRPC) to bones. This study aimed to describe the clinical character...

(This article belongs to the Section Genitourinary Oncology)

of 2

XFacebookLinkedIn
Curr. Oncol. - ISSN 1718-7729